[1]
M. Morales A, J. Ortega M, and C. Campos-Estrada, “NLRP3 inflammasome as a therapeutic target in cardiovascular diseases: An update of preclinical and clinical evidence”, JICRCR, pp. 1361–1377, Jun. 2024.